CN105367585B - 左氧氟沙星杂质的制备方法 - Google Patents
左氧氟沙星杂质的制备方法 Download PDFInfo
- Publication number
- CN105367585B CN105367585B CN201510865425.3A CN201510865425A CN105367585B CN 105367585 B CN105367585 B CN 105367585B CN 201510865425 A CN201510865425 A CN 201510865425A CN 105367585 B CN105367585 B CN 105367585B
- Authority
- CN
- China
- Prior art keywords
- impurity
- preparation
- levofloxacin
- solid
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012535 impurity Substances 0.000 title claims abstract description 67
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 title claims abstract description 22
- 229960003376 levofloxacin Drugs 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 30
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims abstract description 24
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000004440 column chromatography Methods 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 10
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019253 formic acid Nutrition 0.000 claims abstract description 8
- -1 methyl ethylenediamines hydrochloride Chemical class 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 44
- 239000007787 solid Substances 0.000 claims description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 5
- KFIGICHILYTCJF-UHFFFAOYSA-N n'-methylethane-1,2-diamine Chemical compound CNCCN KFIGICHILYTCJF-UHFFFAOYSA-N 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 4
- TTYAMYGZPMSITF-UHFFFAOYSA-N n'-methylethane-1,2-diamine;dihydrochloride Chemical compound Cl.Cl.CNCCN TTYAMYGZPMSITF-UHFFFAOYSA-N 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 23
- 229960001699 ofloxacin Drugs 0.000 description 12
- 239000004519 grease Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000010606 normalization Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- LCRVIUZAMYNZOC-UHFFFAOYSA-N n'-methylethane-1,2-diamine;hydrochloride Chemical compound Cl.CNCCN LCRVIUZAMYNZOC-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010525 oxidative degradation reaction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010583 slow cooling Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- UOBPHQJGWSVXFS-UHFFFAOYSA-N [O].[F] Chemical compound [O].[F] UOBPHQJGWSVXFS-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- OHHBFEVZJLBKEH-UHFFFAOYSA-N ethylenediamine dihydrochloride Chemical compound Cl.Cl.NCCN OHHBFEVZJLBKEH-UHFFFAOYSA-N 0.000 description 1
- 229940089519 levaquin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510865425.3A CN105367585B (zh) | 2015-12-02 | 2015-12-02 | 左氧氟沙星杂质的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510865425.3A CN105367585B (zh) | 2015-12-02 | 2015-12-02 | 左氧氟沙星杂质的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105367585A CN105367585A (zh) | 2016-03-02 |
CN105367585B true CN105367585B (zh) | 2017-11-17 |
Family
ID=55370267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510865425.3A Active CN105367585B (zh) | 2015-12-02 | 2015-12-02 | 左氧氟沙星杂质的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105367585B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0206283A2 (en) * | 1985-06-20 | 1986-12-30 | Daiichi Pharmaceutical Co., Ltd. | Optically active pyridobenzoxazine derivatives |
CN102775424A (zh) * | 2012-07-09 | 2012-11-14 | 浙江司太立制药股份有限公司 | 一种左氧氟沙星杂质的制备方法 |
CN103360410A (zh) * | 2012-04-06 | 2013-10-23 | 河南天方药业股份有限公司 | 氧氟沙星制备方法 |
-
2015
- 2015-12-02 CN CN201510865425.3A patent/CN105367585B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0206283A2 (en) * | 1985-06-20 | 1986-12-30 | Daiichi Pharmaceutical Co., Ltd. | Optically active pyridobenzoxazine derivatives |
CN103360410A (zh) * | 2012-04-06 | 2013-10-23 | 河南天方药业股份有限公司 | 氧氟沙星制备方法 |
CN102775424A (zh) * | 2012-07-09 | 2012-11-14 | 浙江司太立制药股份有限公司 | 一种左氧氟沙星杂质的制备方法 |
Non-Patent Citations (2)
Title |
---|
Oxidation of ofloxacin by Oxone/Co2+:identification of reaction products and pathways;Yunqing Pi et al.;《Environ Sci Pollut Res》;20131101;第21卷;第3031-3040页 * |
Photodegradation products of levofloxacin in aqueous solution;Y.Yoshida et al.;《Drug.Res.》;19931231;第43卷(第1期);第601-606页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105367585A (zh) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016348402B2 (en) | Inhibitors of RET | |
WO2016127074A1 (en) | 2-(pyridin-3-yl)-pyrimidine derivatives as ret inhibitors | |
CA2907502A1 (en) | Benzimidazolone derivatives as bromodomain inhibitors | |
CN107406453A (zh) | 一种btk激酶抑制剂的结晶形式及其制备方法 | |
CN104470898A (zh) | 环烷基甲酸类衍生物、其制备方法及其在医药上的应用 | |
CN103360391A (zh) | 阿哌沙班新晶型及其制备方法 | |
CN111825664B (zh) | 一种川芎嗪衍生物、制备方法和医药用途 | |
CN102675018B (zh) | 制备氘代二苯基脲的方法 | |
CN106795116B (zh) | 一种mek激酶抑制剂的对甲苯磺酸盐、其结晶形式及制备方法 | |
CN105367585B (zh) | 左氧氟沙星杂质的制备方法 | |
CN106748961A (zh) | 尼达尼布的杂质化合物、制备方法、应用及其检测方法 | |
CN106939002B (zh) | 一种btk激酶抑制剂的结晶形式及其制备方法 | |
CN108264500B (zh) | 取代的2-氨基吡啶类化合物及制备方法 | |
CN107163036A (zh) | 一种含噻唑环5,6‑二取代吡啶‑2‑酮化合物及其制备方法 | |
CN107501270A (zh) | 一种含有磺酰吖丙啶结构的化合物、药物组合物以及其应用 | |
JPWO2017026119A1 (ja) | 5−(チアゾール−4−イル)インドリン−2−オン誘導体の精製方法 | |
CN106905236A (zh) | 布南色林及其制备方法 | |
CN109704988B (zh) | 与Aβ蛋白和Tau蛋白具有高亲和力的双腙类化合物及其衍生物与应用 | |
CN106565615A (zh) | 一种磺胺多辛衍生物的制备方法 | |
EP3002286B1 (en) | Preparation method for polymorphic 6-(4-chlorophenoxy)-tetrazolo[5,1-a]phthalazine and use thereof | |
CN116874465B (zh) | 嘧啶类化合物及其应用 | |
CN116813608B (zh) | 噻唑类化合物及其应用 | |
CN107698473B (zh) | 一种五羟色胺转运体显像剂[18f]fpbm-ⅱ的标记前体及标记方法 | |
CN114685439A (zh) | 一种拉司米地坦的制备方法 | |
CN108690028B (zh) | 一种l-缬氨酸取代马来酰亚胺衍生物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Peng Inventor after: Zhang Tao Inventor after: Dong Xu Inventor after: Liu Wenkun Inventor after: Liu Haiping Inventor after: Qi Lin Inventor after: Xu Wendong Inventor before: Wang Peng Inventor before: Zhang Tao Inventor before: Cao Peng Inventor before: Liu Wenkun Inventor before: Liu Haiping |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of levofloxacin impurity Effective date of registration: 20211202 Granted publication date: 20171117 Pledgee: CITIC Bank Limited by Share Ltd. Zibo branch Pledgor: SHANDONG QIDU PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980013861 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220719 Granted publication date: 20171117 Pledgee: CITIC Bank Limited by Share Ltd. Zibo branch Pledgor: SHANDONG QIDU PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980013861 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of impurities in levofloxacin Effective date of registration: 20231206 Granted publication date: 20171117 Pledgee: Shandong Linzi Rural Commercial Bank Co.,Ltd. Pledgor: SHANDONG QIDU PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980069709 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20171117 Pledgee: Shandong Linzi Rural Commercial Bank Co.,Ltd. Pledgor: SHANDONG QIDU PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980069709 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |